Transcription Activation-Based Herb-Drug Interactions

Information

  • Research Project
  • 7665493
  • ApplicationId
    7665493
  • Core Project Number
    F05AT003019
  • Full Project Number
    5F05AT003019-05
  • Serial Number
    3019
  • FOA Number
    PA-03-050
  • Sub Project Id
  • Project Start Date
    8/1/2005 - 19 years ago
  • Project End Date
    7/31/2010 - 14 years ago
  • Program Officer Name
    HAYES, DEBORAH
  • Budget Start Date
    8/1/2009 - 15 years ago
  • Budget End Date
    7/31/2010 - 14 years ago
  • Fiscal Year
    2009
  • Support Year
    5
  • Suffix
  • Award Notice Date
    8/20/2009 - 15 years ago

Transcription Activation-Based Herb-Drug Interactions

DESCRIPTION (provided by applicant): The long-term objective of the project is to elucidate the molecular basis for herb-drug interactions, and to develop molecular-based technologies to predict such interactions. The major objective of this project is to reveal molecular details involving the activation of the pregnane X receptor (PXR) by Chinese herbal extracts and model compounds hyperforin and guggulsterone. The model compounds represent the most used herbal supplements, and are shown to activate PXR. Activation of this receptor markedly induces the expression of drug-metabolizing enzymes, resulting in severe herb-drug interactions. PXR is a member of the nuclear receptor superfamily, and recruits very same coactivators as other nuclear receptors. Interestingly, hyperforin is more potent toward human PXR, whereas guggulsterone is more potent toward rodent PXRs. The goals of this project are: (1) to determine the structural basis for the species-preferable activation;(2) to determine whether Chinese herbal extracts, known to induce drug-metabolizing enzymes, activate PXR;(3) to determine whether depletion of coactivators reduces hyperforin-mediated activation of PXR;and (4) to provide the applicant with a much-needed exercise on high-end molecular techniques.

IC Name
NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE
  • Activity
    F05
  • Administering IC
    AT
  • Application Type
    5
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    32000
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    213
  • Ed Inst. Type
  • Funding ICs
    NCCAM:32000\
  • Funding Mechanism
    Other Research Related
  • Study Section
    ZAT1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    NANJING MEDICAL UNIVERSITY
  • Organization Department
  • Organization DUNS
    420026593
  • Organization City
    NANJING
  • Organization State
  • Organization Country
    CHINA
  • Organization Zip Code
    210029
  • Organization District
    CHINA